Search

Author/Creator Kiermayr, Sigrid

1. Antibody Persistence up to 3 Years After Primary Immunization With Inactivated Japanese Encephalitis Vaccine IXIARO in Philippine Children and Effect of a Booster Dose. Issue 9 (September 2018)

Authors:
Kadlecek, Vera; Borja-Tabora, Charissa Fay; Eder-Lingelbach, Susanne; Gatchalian, Salvacion; Kiermayr, Sigrid; Sablan, Benjamin; Kundi, Michael; Taucher, Christian; Dubischar, Katrin L.
Journal:
Pediatric infectious disease journal
Issue:
Volume 37:Issue 9(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Immunogenicity of the Inactivated Japanese Encephalitis Virus Vaccine IXIARO in Children From a Japanese Encephalitis Virus-endemic Region. Issue 9 (September 2017)

Authors:
Dubischar, Katrin L.; Kadlecek, Vera; Sablan, Benjamin; Borja-Tabora, Charissa Fay; Gatchalian, Salvacion; Eder-Lingelbach, Susanne; Kiermayr, Sigrid; Spruth, Martin; Westritschnig, Kerstin
Journal:
Pediatric infectious disease journal
Issue:
Volume 36:Issue 9(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Neutralizing antibody persistence in pediatric travelers from non-JE-endemic countries following vaccination with IXIARO® Japanese encephalitis vaccine: An uncontrolled, open-label phase 3 follow-up study. Issue 34 (March 2020)

Authors:
Taucher, Christian; Barnett, Elizabeth D.; Cramer, Jakob P.; Eder-Lingelbach, Susanne; Jelinek, Tomas; Kadlecek, Vera; Kiermayr, Sigrid; Mills, Deborah J.; Pandis, Duellyn; Reiner, Daniela; Dubischar, Katrin L.
Journal:
Travel medicine and infectious disease
Issue:
Issue 34(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO®, JESPECT®) in a pediatric population in JE non-endemic countries: An uncontrolled, open-label phase 3 study. Issue 22 (March 2018)

Authors:
Jelinek, Tomas; Cromer, Michael A.; Cramer, Jakob P.; Mills, Deborah J.; Lessans, Kenneth; Gherardin, Anthony W.; Barnett, Elizabeth D.; Hagmann, Stefan H.F.; Askling, Helena H.; Kiermayr, Sigrid; Kadlecek, Vera; Eder-Lingelbach, Susanne; Taucher, Christian; Dubischar, Katrin L.
Journal:
Travel medicine and infectious disease
Issue:
Issue 22(2018)
Page Start:
18
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers. Issue 23 (17th May 2016)

Authors:
Bézay, Nicole; Ayad, Andrea; Dubischar, Katrin; Firbas, Christa; Hochreiter, Romana; Kiermayr, Sigrid; Kiss, István; Pinl, Fritz; Jilma, Bernd; Westritschnig, Kerstin
Journal:
Vaccine
Issue:
Volume 34:Issue 23(2016)
Page Start:
2585
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗